MyFinsight
Home
Blog
About
BioScience Health Innovations, Inc. (BHICD)
BioScience Health Innovations, Inc. (BHICD)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$476,906
Unit: Dollar
Positive Cash Flow Breakdown
Advances from related parties
Net income (loss)
Deferred revenue
Others
Negative Cash Flow Breakdown
Repayment to related parties
Inventory
Purchase of intangible assets
Prepaid expenses
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
Net income (loss)
875,720
Accounts receivable
-37,073
Inventory
699,181
Deferred revenue
86,662
Accrued services
693
Accounts payable
1,939
Prepaid expenses
30,032
Net cash provided by (used in) operating activities
272,874
Purchase of intangible assets
46,064
Advances from related parties
2,422,096
Repayment to related parties
2,172,000
Proceeds from the sale of common stock
0
Net cash provided by financing activities
250,096
Net increase in cash
476,906
Cash and cash equivalents at beginning of period
662,517
Cash and cash equivalents at end of period
1,139,423
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income (loss)
$875,720
Advances from related
parties
$2,422,096
Deferred revenue
$86,662
Accounts receivable
-$37,073
Accounts payable
$1,939
Accrued services
$693
Net cash provided by
(used in) operating...
$272,874
Net cash provided by
financing activities
$250,096
Canceled cashflow
$729,213
Canceled cashflow
$2,172,000
Net increase in cash
$476,906
Canceled cashflow
$46,064
Inventory
$699,181
Prepaid expenses
$30,032
Repayment to related
parties
$2,172,000
Purchase of intangible
assets
$46,064
Buy us a coffee